EUVIMEDEUVIMED entdecken
Open Access

Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI

Masaaki Nakase, Taishi Okuno, Daijiro Tomii, Bashir Alaour, Fabien Praz, Stefan Stortecky, Jonas Lanz, David Reineke, Stephan Windecker, Thomas Pilgrim

EuroIntervention · 2023

DOI: 10.4244/eij-d-23-00590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EuroIntervention, 2023. Verfasst von Masaaki Nakase und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The prognostic value of cardiac damage staging classifications across the haemodynamic spectrum of severe aortic stenosis (AS) remains unknown. AIMS: We aimed to investigate the prognostic impact of cardiac damage staging classifications in patients with high-gradient AS (HG-AS) and low-gradient AS (LG-AS) undergoing transcatheter aortic valve implantation (TAVI). METHODS: In a prospective TAVI registry, five-year mortality was evaluated for early stages of cardiac damage (stage 0, 1, or 2) and advanced stages of cardiac damage (stage 3 or 4) in patients with HG-AS, classical low-flow (LF) LG-AS, LF LG-AS with preserved ejection fraction (pEF), and normal-flow (NF) LG-AS. RESULTS: Among 2,090 patients undergoing TAVI, 1,045 patients had HG-AS, 337 patients had classical LF LG-AS, 394 patients had LF LG-AS with pEF, and 314 patients had NF LG-AS. The majority of patients with classical LF LG-AS exhibited advanced cardiac damage (73.6%), followed by LF LG-AS with pEF (55.6%), NF LG-AS (51.6%), and HG-AS (50.6%). Patients with advanced stage cardiac damage had significantly higher mortality after TAVI than those with early stage cardiac damage in all subtypes of AS (adjusted hazard ratio [HRadjusted] 1.66, 95% confidence interval [CI]: 1.34-2.06 for HG-AS; HRadjusted 1.49, 95% CI: 1.02-2.16 for classical LF LG-AS; HRadjusted 1.69, 95% CI: 1.22-2.35 for LF LG-AS with pEF; and HRadjusted 1.52, 95% CI: 1.04-2.32 for NF LG-AS). CONCLUSIONS: Cardiac damage staging classifications stratified mortality after TAVI irrespective of AS subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisHumansPrognosisProspective StudiesStroke VolumeTreatment OutcomeAortic ValveSeverity of Illness IndexVentricular Function, Left

Autor:innen und Institutionen

  • Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
  • Department of Cardiovascular Surgery, Inselspital, University of Bern, Bern, Switzerland.

Zitieren

APA

Nakase, M., Okuno, T., Tomii, D., Alaour, B., Praz, F., Stortecky, S., Lanz, J., Reineke, D., Windecker, S., & Pilgrim, T. (2023). Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI. EuroIntervention. https://doi.org/10.4244/eij-d-23-00590

Vancouver

Nakase M, Okuno T, Tomii D, Alaour B, Praz F, Stortecky S, et al. Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI. EuroIntervention. 2023. doi:10.4244/eij-d-23-00590

BibTeX
@article{Nakase2023,
  author = {Nakase, Masaaki and Okuno, Taishi and Tomii, Daijiro and Alaour, Bashir and Praz, Fabien and Stortecky, Stefan and Lanz, Jonas and Reineke, David and Windecker, Stephan and Pilgrim, Thomas},
  title = {Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI},
  journal = {EuroIntervention},
  year = {2023},
  doi = {10.4244/eij-d-23-00590}
}
Kostenlos starten →